《中国心肺复苏专家共识》之静脉血栓栓塞性CA指南

2019-01-16 中国研究型医院学会 中华危重病急救医学. 2018,30(12):1107-1116.

由中国研究型医院学会心肺复苏学专业委员会组织,联合中国老年保健协会心肺复苏专业委员会、中华医学会科学普及分会心肺复苏专家指导委员会、北京医学会灾难医学与心肺复苏分会、全军重症医学专业委员会心肺复苏学组、武警部队危重病专业委员会心肺复苏学组等组成《中国心肺复苏专家共识》编委会,特颁布《〈中国心肺复苏专家共识〉之静脉血栓栓塞性CA 指南》。

中文标题:

《中国心肺复苏专家共识》之静脉血栓栓塞性CA指南

发布机构:

中国研究型医院学会

发布日期:

2019-01-16

简要介绍:

由中国研究型医院学会心肺复苏学专业委员会组织,联合中国老年保健协会心肺复苏专业委员会、中华医学会科学普及分会心肺复苏专家指导委员会、北京医学会灾难医学与心肺复苏分会、全军重症医学专业委员会心肺复苏学组、武警部队危重病专业委员会心肺复苏学组等组成《中国心肺复苏专家共识》编委会,特颁布《〈中国心肺复苏专家共识〉之静脉血栓栓塞性CA 指南》。 

拓展指南:血栓相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=《中国心肺复苏专家共识》之静脉血栓栓塞性CA指南)] GetToolGuiderByIdResponse(projectId=1, id=9721f1c00169e128, title=《中国心肺复苏专家共识》之静脉血栓栓塞性CA指南, enTitle=, guiderFrom=中华危重病急救医学. 2018,30(12):1107-1116., authorId=null, author=, summary=由中国研究型医院学会心肺复苏学专业委员会组织,联合中国老年保健协会心肺复苏专业委员会、中华医学会科学普及分会心肺复苏专家指导委员会、北京医学会灾难医学与心肺复苏分会、全军重症医学专业委员会心肺复苏学组、武警部队危重病专业委员会心肺复苏学组等组成《中国心肺复苏专家共识》编委会,特颁布《〈中国心肺复苏专家共识〉之静脉血栓栓塞性CA 指南》。 , cover=, journalId=null, articlesId=null, associationId=1023, associationName=中国研究型医院学会, associationIntro=中国研究型医院学会,英文名称Chinese Research Hospital Association(CRHA),是经国家民政部正式批复并登记注册的全国性一级学会,是独立的法人社团。中国研究型医院学会是由以探索和建设研究型医院为目标的具有医疗服务、科学研究和临床教学&ldquo;三位一体&rdquo;功能的医疗机构,以及从事研究型医院理论与实践研究的人员自愿结成的全国性、专业性、学术性、非营利性社会组织。, copyright=0, guiderPublishedTime=Wed Jan 16 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>由中国研究型医院学会心肺复苏学专业委员会组织,联合中国老年保健协会心肺复苏专业委员会、中华医学会科学普及分会心肺复苏专家指导委员会、北京医学会灾难医学与心肺复苏分会、全军重症医学专业委员会心肺复苏学组、武警部队危重病专业委员会心肺复苏学组等组成《中国心肺复苏专家共识》编委会,特颁布《〈中国心肺复苏专家共识〉之静脉血栓栓塞性CA 指南》。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>血栓</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=c8e601c00168803b" title="2019 SNIS报告:急性缺血性卒中紧急大血管闭塞血栓切除术的适应证" target=_blank>2019 SNIS报告:急性缺血性卒中紧急大血管闭塞血栓切除术的适应证</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5a49a1c0016821cc" title="2018 CUA指南:围术期血栓预防和抗凝治疗" target=_blank>2018 CUA指南:围术期血栓预防和抗凝治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=184251c0016e9169" title="2018 ESC共识:急性深静脉血栓形成的诊断和管理" target=_blank>2018 ESC共识:急性深静脉血栓形成的诊断和管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9c6711c0016ea294" title="中国血栓性疾病防治指南" target=_blank>中国血栓性疾病防治指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=36f821c0016e2935" title="2018 ASH静脉血栓栓塞管理指南:儿童静脉血栓栓塞症的治疗" target=_blank>2018 ASH静脉血栓栓塞管理指南:儿童静脉血栓栓塞症的治疗</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E6%A0%93" target=_blank>有关血栓更多指南</a></ul>, tagList=[TagDto(tagId=86264, tagName=静脉血栓栓塞性), TagDto(tagId=454, tagName=心脏停搏)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8556, appHits=626, showAppHits=2, pcHits=7029, showPcHits=1632, likes=332, shares=28, comments=11, approvalStatus=1, publishedTime=Wed Feb 06 20:45:57 CST 2019, publishedTimeString=2019-01-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Feb 06 20:45:57 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 11:15:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=《中国心肺复苏专家共识》之静脉血栓栓塞性CA指南)])
《中国心肺复苏专家共识》之静脉血栓栓塞性CA指南
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214696, encodeId=9c1912146968b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:32:48 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976066, encodeId=9c519e606646, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=北大V, createdTime=Wed Jun 23 09:27:23 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976065, encodeId=7d889e6065ae, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:26:13 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976064, encodeId=c2589e60643e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:24:02 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976063, encodeId=35ef9e6063f9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:23:50 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214696, encodeId=9c1912146968b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:32:48 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976066, encodeId=9c519e606646, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=北大V, createdTime=Wed Jun 23 09:27:23 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976065, encodeId=7d889e6065ae, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:26:13 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976064, encodeId=c2589e60643e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:24:02 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976063, encodeId=35ef9e6063f9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:23:50 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-06-23 北大V

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214696, encodeId=9c1912146968b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:32:48 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976066, encodeId=9c519e606646, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=北大V, createdTime=Wed Jun 23 09:27:23 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976065, encodeId=7d889e6065ae, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:26:13 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976064, encodeId=c2589e60643e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:24:02 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976063, encodeId=35ef9e6063f9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:23:50 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-06-23 ms4000001300122982

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214696, encodeId=9c1912146968b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:32:48 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976066, encodeId=9c519e606646, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=北大V, createdTime=Wed Jun 23 09:27:23 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976065, encodeId=7d889e6065ae, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:26:13 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976064, encodeId=c2589e60643e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:24:02 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976063, encodeId=35ef9e6063f9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:23:50 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-06-23 ms4000001300122982

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214696, encodeId=9c1912146968b, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:32:48 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976066, encodeId=9c519e606646, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=北大V, createdTime=Wed Jun 23 09:27:23 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976065, encodeId=7d889e6065ae, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:26:13 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976064, encodeId=c2589e60643e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:24:02 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976063, encodeId=35ef9e6063f9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210623/5ee3c2ad3f524a9faf869516459b18c9/58956fa9e1df459394845ddfd8944297.jpg, createdBy=2d855531872, createdName=ms4000001300122982, createdTime=Wed Jun 23 09:23:50 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-06-23 ms4000001300122982

    0